Sunday, February 12, 2012

New ADHD med moves into late-stage studies

(Forbes) UPDATED 2009-07-15
Drugmaker Tergacept's experimental ADHD medication is being moved into late-stage clinical trails, according to the company. The drug--known as AZD3480 or TC-1734--has already completed mid-stage trials for ADHD, as well as for Alzheimer's and Schizophrenia. The medication is part of a new class of drugs called neuronal nicotinic receptor therapeutics, which are aimed at treating central nervous system disorders.  Read full story >
See all ADHD News

People who read this also read...